MedTrace Logo

Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study

NCT05895279 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2024-11-04

No results posted yet for this study

Summary

This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Conditions

  • Prostate Carcinoma

Interventions

OTHER

Media Intervention

Watch MiCaP Research Digest video

OTHER

Media Intervention

Watch alternate video

OTHER

Survey Administration

Complete survey

Sponsors & Collaborators

Principal Investigators

  • Folakemi T. Odedina, Ph.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-02
Primary Completion
2021-10-01
Completion
2021-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05895279 on ClinicalTrials.gov